Home › Compare › TOAGF vs ABBV
TOAGF yields 4.71% · ABBV yields 3.06%● Live data
📍 TOAGF pulled ahead of the other in Year 1
Combined, TOAGF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TOAGF + ABBV for your $10,000?
Toagosei Co., Ltd., together with its subsidiaries, manufactures, distributes, and sells chemical products in Japan and internationally. The company operates through Commodity Chemicals, Polymer & Oligomer, Adhesive Material, Performance Chemicals, and Plastics segment. It offers inorganic products, including liquid caustic soda, liquid chlorine, synthetic hydrochloric acid, sodium hypochlorite, caustic and super potash, sulfuric acid, sodium sulfite, potassium pyrophosphate, and copper oxide, as well as iron perchloride, hypochiorous acid, copper pyrophosphate, and copper potassium pyrophosphate solutions; chlorinated solvents, such as trichlorethylene and tetrachlorethylene; and ammonium sulfate and potassium bicarbonate fertilizers. The company also provides acrylic monomers; acrylamide tertiary butyl sulfonic acid and ethylene carbonate; acrylic polymers, such as dispersants, thickeners, scale inhibitors, pressure sensitive adhesives, binders, paint vehicles, and gelling agents; special polymers; solvent-free acrylic polymers; special acrylic monomers; polymer flocculants; and UV-curable resins. Further, the company provides instant glues and functional adhesives; inorganic chemicals, such as liquid hydrogen chloride, and hexachlorodisilane, as well as potassium hydroxide and carbonate aqueous, and ferric chloride solutions; and inorganic functional materials, including electronic materials and amenity care materials. Additionally, it offers industrial gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, and mixed gas; and products for the construction and civil engineering. The company was founded in 1933 and is headquartered in Tokyo, Japan.
Full TOAGF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.